BPIQ Blog

$XBI $135 -2% Covid Updates $RVVTF +6% Research agreement with UCSF for Bucillamine as potential treatment for severe Covid-19. source...

$XBI $137 -1% Covid Updates $SYGGF -19% Ph 2 covid data. source $BTNX +5% & $PFE Request CMA in EU expansion to ages 12 to 15. source...

$XBI $138.06 -1.17% Covid Updates $VRNA -5.56% Last week ensifentrine reported was well tolerated in patients hospitalized with COVID-19....

$XBI $140 +1% Covid Updates $AMPE +3% Phase 1 data for AP-014 for respiratory distress in patients as a result of COVID-19. source...

$XBI $139.35 +0.28% Pipeline Updates $SLGL -12.7% Sol-Gel received no notification from FDA of approval of EPSOLAY; pre-approval...

$XBI $139 +4% Covid Updates $GILD +1% Announces plans to expand Remdesivir in India. source $MRNA +2% Entered into agreement with Sanofi...

$XBI $134.30 -0.2% Covid Updates $INO -25% US govt will not fund Ph3 due to increased EUA vaccines in the U.S. Ph3 trial to be ex-US....

$XBI $134 +2% Pipeline Updates $TRIL -5% Will host investor day 4/18. Clinical updates for TTI-622 and TTI-621, updated 2021 milestones...

$XBI $132.77 +3.49% Covid Updates $OCGN +6.5% Co-development partner shared positive Phase 3 results on COVAXIN. source $DVAX +5.0%...

$XBI $128.29 -1% Covid Updates $MRNA -3% Supply agreement with Israel for 2022. source $SRNE -1% Announces ph 1 results of COVI-MSC in...

$XBI $131.55 -1.5% Pipeline Updates $ZGNX -3.4% New findings of FINTEPLA on patients with Dravet Syndrome. source $SNDX -2.7% AUGMENT-101...

$XBI $133 +1% Covid Updates $VIR -2% EMA has started review on VIR-7831 for covid. source $CYDY +8% Supply and distribution agreement for...

What is the readout? FDA approval decision deadline date (PDUFA) for tenapanor, a novel product candidate to control serum phosphorus in...

$XBI $132.32 +2.7% Covid Updates $MRNA +6.9% Announces clinical progress from leading mRNA vaccine. source Pipeline Updates $LUMO +5.8%...

$XBI $129 +2% Covid Updates $MRNA +10% Supply update. source $RIGL +15% Ph 2 data in hospitalized covid-19 patients. source Pipeline...

$XBI $127 -2% Covid Updates $KNSA -9% Ph 2 data in severe covid-19 patients. source Pipeline Updates $IMCR -6% ph 3 data presented at...

Tiziana Life Sciences (TLSA) was up today over 17% today on almost 20x higher than average volume. So what drove the price increase? We...

$XBI $129 -2% Covid Updates $RDHL +9% Phase 2/3 COVID-19 Opaganib study unanimously recommended to continue. source $CYDY +1% Leronlimab...

$XBI $132.57 +1% Covid Updates $IBRX -1% Preliminary Phase 1b data reported. source $MRNA +2% Publication of antibody persistence data...

Yesterday, after hours, $FGEN shares plunged as it announced "clarification" to prior disclosures of cardiovascular safety for its HIF-PH...